TrumpRX: Medicare’s New Weight Loss Coke—Now in Pill Form!
In a twist messier than a TikTok diet challenge, the Trump administration is creeping towards a pharma bromance with Eli Lilly and Novo Nordisk to make weight loss drugs like Wegovy and Zepbound cheaper and Medicare-eligible. Imagine Wegovy dropping to $149/month on TrumpRX (official whitehouse-tool-for-shedding-bills) while Zepbound flexes at $299. Oh, and remember the April 2025 sabotage of Biden’s $40B idea to cover these magic needles? Yeah, now Trump’s shopping that buffet again, aiming to cover these drugs for both Medicare and possibly Medicaid users. Half of obese seniors were already halfway in before this saga even began.
Share the Story
Trump's Medicare deal lets seniors lose weight for less while confusing the internet about who really hates spending big on drugs. Meanwhile, Wegovy and Zepbound are like the overpriced avocado toast of pharmaceuticals – now 'affordable' at hundreds a month!
Medicare covering weight loss drugs finally proves the government cares about more than just Twitter polls and obscure middle names.
Drug companies dropping prices on weight loss meds after politics does the math feels like your diet: inconsistent, overpriced, but somehow still hopeful.
Source: Axios | Published: 11/4/2025 | Author: Caitlin Owens
More Articles in Health
Politico Announces Australia Launch for 2026, Because Why Not Start Late?
Trump Promises Retirement Plan That Matches Generosity of Federal Workers’ Excuses
Trump Calls Supreme Court 'Unfortunate,' Then Hits Economy with ‘Better’ 10% Global Tariff
Mom Skips Junior Year Exams, Swaps Algebra for Penguins in Antarctica
America Solves Fentanyl Crisis by Inventing Pink Cocaine Zombie Apocalypse
French Obesity Rate Mystifies US After Cheese, Wine, Bread Diet Approved
Woman Waited Years to Wear Favorite Clothes; Life Finally Happened, Clothes Revolted
RFK Jr. Promises To Investigate Ultra-Processed Junk Food but Won't Regulate It
